ConductScience.org, home

Paper39499348

Efficacy of XEN gel stent implantation combined with mitomycin C injection in the treatment of open-angle glaucoma: a meta-analysis.

Feng H and 1 other. Int Ophthalmol, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Efficacy of XEN gel stent implantation combined with mitomycin C injection in the treatment of open-angle glaucoma: a meta-analysis. Papers, record 39499348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39499348

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of XEN gel stent implantation combined with mitomycin C injection in the treatment of open-angle glaucoma: a meta-analysis.
PubMed
Journal
Int Ophthalmol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Meta-Analysis
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
1.5, provisional
iCite
Revised in PubMed
2025-03-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Feng HHong
2Zhang ZZhonghong

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Glaucoma Drainage ImplantsMajor topic
Glaucoma, Open-AngleMajor topic
Intraocular PressureMajor topic
MitomycinMajor topic
StentsMajor topic
Humans
Alkylating Agents
Combined Modality Therapy
Injections, Intraocular
Treatment Outcome

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129356886The XEN45 Gel Stent as a minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries.Graefes Arch Clin Exp Ophthalmol2018https://conductscience.org/library/papers/29356886PubMed
232052260XEN Gel Stent in the management of primary open-angle glaucoma.Doc Ophthalmol2020https://conductscience.org/library/papers/32052260PubMed
320652370Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.Eur J Epidemiol2010https://conductscience.org/library/papers/20652370PubMed
427544023The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes.Ophthalmology2016https://conductscience.org/library/papers/27544023PubMed
526995503Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions.Arch Soc Esp Oftalmol2016https://conductscience.org/library/papers/26995503PubMed
631729825Primary baerveldt versus trabeculectomy study after 5 years of follow-up.Acta Ophthalmol2020https://conductscience.org/library/papers/31729825PubMed
710420107A major review of antimetabolites in glaucoma therapy.Ophthalmologica1999https://conductscience.org/library/papers/10420107PubMed
832930515Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors.Acta Ophthalmol2021https://conductscience.org/library/papers/32930515PubMed
932310972Efficacy and safety of XEN®-Implantation vs. trabeculectomy: Data of a "real-world" setting.PLoS One2020https://conductscience.org/library/papers/32310972PubMed
109310563Bias in meta-analysis detected by a simple, graphical test.BMJ1997https://conductscience.org/library/papers/9310563PubMed
1135743517Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent.J Clin Med2022https://conductscience.org/library/papers/35743517PubMed
1224974815Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.Ophthalmology2014https://conductscience.org/library/papers/24974815PubMed
1328751986Evaluation of Bleb Morphology and Reduction in IOP and Glaucoma Medication following Implantation of a Novel Gel Stent.J Ophthalmol2017https://conductscience.org/library/papers/28751986PubMed
1431633616Urgent Management of Secondary Glaucoma in Uveitis Using the Xen-45 Gel Stent.J Glaucoma2019https://conductscience.org/library/papers/31633616PubMed
1530113511Needling With 5-Fluorouracil (5-FU) After XEN Gel Stent Implantation: 6-Month Outcomes.J Glaucoma2018https://conductscience.org/library/papers/30113511PubMed
1628348884XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications.J Ophthalmol2017https://conductscience.org/library/papers/28348884PubMed
1732996702Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma.Acta Ophthalmol2021https://conductscience.org/library/papers/32996702PubMed
1834187146A Retrospective Analysis of Safety and Efficacy of XEN 45 Microstent Combined Cataract Surgery in Open-Angle Glaucoma over 24 MonthsTurk J Ophthalmol2021https://conductscience.org/library/papers/34187146PubMed
1919622552The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.BMJ2009https://conductscience.org/library/papers/19622552PubMed
2033867756Comparison of Ab Interno XEN Gelatin Stent vs Trabeculectomy with Mitomycin C: A Retrospective Study.J Curr Glaucoma Pract2020https://conductscience.org/library/papers/33867756PubMed

See all 40 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42646826Glaucoma Filtration Surgery in Rabbit Pre-Clinical Models: Design, Drug Dosing and Reporting Practices 2011-2025.Vision (Basel)2026https://conductscience.org/library/papers/42646826PubMed
42377416Functional assessment of the XEN® Gel Stent relative to the implant position using non-invasive stress testing and automated gonioscopy.Graefes Arch Clin Exp Ophthalmol2026https://conductscience.org/library/papers/42377416PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39499348

GET https://conductscience.org/api/papers/v1/39499348/references?page=2